• Home
  • About
  • Repositories
  • Search
  • Web API
  • Feedback
<< Go Back

Metadata

Name
Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Repository
ClinicalTrials.gov
Identifier
clinicaltrials:NCT00271635
Description
Charcot-Marie-Tooth type IA (CMT1A) is the most prevalent hereditary peripheral neuropathy.
Demyelination of peripheral nerves is the hallmark of CMT1A. Ascorbic acid has been shown to
have a favorable influence on myelination in in vitro studies and in a mouse model for CMT1A.
We will study the efficacy and safety of ascorbic acid treatment in young patients with
CMT1A.
Data or Study Types
clinical trial
Keywords
Hereditary Motor and Sensory Neuropathies, Ascorbic Acid, Charcot-Marie-Tooth Disease, Vitamin C
Source Organization
Unknown
Access Conditions
available
Year
2006
Access Hyperlink
https://clinicaltrials.gov/ct2/show/NCT00271635

Distributions

  • Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT00271635
This project was funded in part by grant U24AI117966 from the NIH National Institute of Allergy and Infectious Diseases as part of the Big Data to Knowledge program. We thank all members of the bioCADDIE community for their valuable input on the overall project.